skip to main content

    Updated Visitor Guidelines

 

MENU

 

Non-Comparative, Open-Label, Multiple Cohort, Phase 1/2 Study of Nivolumab and Nivolumab Plus Ipilimumab in Subjects With Virus-Positive and Virus-Negative Solid Tumors

This trial is no longer accepting participants. For information / assistance in finding a trial that is right for you, please call Cancer AnswerLine at 800-865-1125.